Prostate cancer cells used in this study expressed IL-6 as a response to immune attack that seemed to be associated with the IGF-1Ec upregulation and PEc secretion, through the activation of JAK2/STA3 pathway (Fig. 5). This evidence concerns the gene IL6 and prostate carcinoma.